ADG153, an Anti-CD47 Monoclonal Antibody Prodrug, Has Strong In Vivo Anti-Tumor Activity, Minimal RBC-Related and Antigen Sink Liabilities, and Extended Half Life in Comparison with Benchmark Clinical Antibodies of the Same IgG Subclass
Bin Cai, Jiangchun Xu(Pfizer (United States)), Yan Li(Beijing Tongren Hospital), Songmao Zheng, Guizhong Liu(Tianjin Hospital), Aaron Nguyen, Felix Du, Jianfeng Shi, Peter Luo
Cited by 4
Related Papers
Whole-genome sequencing and comprehensive molecular profiling identify new driver mutations in gastric cancer
|Nature Genetics|2014|1.1k
Exome sequencing identifies frequent mutation of ARID1A in molecular subtypes of gastric cancer
|Nature Genetics|2011|775
Mobile Photoplethysmographic Technology to Detect Atrial Fibrillation
|Journal of the American College of Cardiology|2019|494
The Anti-Inflammatory Effects of Vitamin D in Tumorigenesis
|International Journal of Molecular Sciences|2018|200
Novel, Chimpanzee Serotype 68-Based Adenoviral Vaccine Carrier for Induction of Antibodies to a Transgene Product
|Journal of Virology|2002|195